This article is more than 5 years old. Information may no longer be current.

FDA clears Topcon 3-D OCT-1 Maestro system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has cleared the 3-D OCT-1 Maestro system in the U.S., Topcon Medical Systems announced in a press release.

The Maestro system combines a high-resolution color nonmydriatic retinal camera with SD-OCT technology and is equipped with PinPoint registration, which indicates the location of the OCT image within the fundus image.

The Maestro system also features a compare function, automatic segmentation of the optic nerve and macula in a 12-mm by 9-mm scan, as well as an extensive reference database, according to the release.

“The Maestro has been one of the best-selling SD-OCTs outside the U.S. for the past 2 years,” John Fujita, president of Topcon, said in the release, adding that Topcon has sold more than 10,000 OCT units globally.